Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renishaw Diagnostics
Glasgow, Scotland, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Renishaw Diagnostics develops and commercializes high-sensitivity, multiplex molecular diagnostic assays for infectious diseases using SERRS technology. Its Fungiplex assay enables early detection of prevalent invasive fungal infections, improving targeted therapy and reducing unnecessary antimicrobial exposure. Additional assays for bacterial gastroenteritis (Gastroplex) and carbapenem resistance (Carbaplex) are under development.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Molecular diagnosticsDevice
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on Renishaw Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Renishaw Diagnostics.